Bank of New York Mellon Corp - FORMA THERAPEUTICS HLDGS INC ownership

FORMA THERAPEUTICS HLDGS INC's ticker is FMTX and the CUSIP is 34633R104. A total of 95 filers reported holding FORMA THERAPEUTICS HLDGS INC in Q4 2021. The put-call ratio across all filers is 2.12 and the average weighting 0.3%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of FORMA THERAPEUTICS HLDGS INC
ValueSharesWeighting
Q3 2022$2,506,000
+250.0%
125,574
+20.8%
0.00%
Q2 2022$716,000
-33.2%
103,958
-9.8%
0.00%
Q1 2022$1,072,000
-35.1%
115,290
-0.8%
0.00%
Q4 2021$1,653,000
-36.9%
116,215
+2.8%
0.00%
-100.0%
Q3 2021$2,621,000
+7.8%
113,038
+15.7%
0.00%
Q2 2021$2,431,000
-1.7%
97,665
+10.7%
0.00%
-100.0%
Q1 2021$2,472,000
+16.0%
88,227
+44.5%
0.00%
Q4 2020$2,131,000
-7.5%
61,054
+32.2%
0.00%
-100.0%
Q3 2020$2,303,00046,1940.00%
Other shareholders

There were no reported owners of FORMA THERAPEUTICS HLDGS INC in Q4 2021.

NameSharesValueWeighting ↓
View complete list of FORMA THERAPEUTICS HLDGS INC shareholders